Targeting cardiovascular and kidney outcomes in CKD: Where do we stand today?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2iThe cardiorenal connection and diabetes: Exploring intervention by SGLT2i
Maria Rosa Costanzo, MD
- Impacting cardiovascular and kidney protection in CKD: The evolving role of SGLT2iKidney protection and SGLT2i: What do we know?
Prof. Mark Cooper, MD